Volume 64, Issue 3, Pages (September 2003)

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Volume 82, Issue 12, Pages (December 2012)

Volume 59, Issue 2, Pages (February 2001)

First-year death rates by modality figure 8

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Volume 62, Issue 3, Pages (September 2002)

Erythropoietin should be part of congestive heart failure management

Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,

Mitchell H. Rosner, W. Kline Bolton Kidney International

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients Jiacong Luo, MD, MS, MPH, Donna E.

Erythropoietin should be part of congestive heart failure management

In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’ Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.

End-stage renal disease in developing countries

Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery Wolfgang C. Winkelmayer, Robert J. Glynn,

Volume 83, Issue 3, Pages (March 2013)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Volume 62, Issue 3, Pages (September 2002)

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

John P. Middleton, Patrick H. Pun Kidney International

Type of vascular access and mortality in U.S. hemodialysis patients

Syncope: Outcomes and Conditions Associated with Hospitalization

Volume 82, Issue 12, Pages (December 2012)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Volume 73, Pages S165-S172 (April 2008)

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,

Volume 79, Pages S9-S13 (April 2011)

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Volume 76, Issue 10, Pages (November 2009)

Volume 80, Issue 9, Pages (November 2011)

Volume 84, Issue 5, Pages (November 2013)

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 86, Issue 4, Pages (October 2014)

Survival advantage in Asian American end-stage renal disease patients1

Volume 68, Issue 5, Pages (November 2005)

Patient selection affects end-stage renal disease outcome comparisons

Stephen P. McDonald Kidney International Supplements

Late referral and modality choice in end-stage renal disease

Body size and outcomes on peritoneal dialysis in the United States

Volume 70, Issue 12, Pages (December 2006)

Volume 69, Issue 10, Pages (May 2006)

Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD

Volume 83, Issue 2, Pages (February 2013)

Methods for guideline development

Volume 76, Issue 8, Pages (October 2009)

Volume 80, Issue 6, Pages (September 2011)

Lynda Anne Szczech, Ira L. Lazar Kidney International

David A. Goodkin, MD, Eric W

Volume 72, Issue 4, Pages (August 2007)

Volume 62, Issue 3, Pages (September 2002)

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 77, Issue 12, Pages (June 2010)

Volume 64, Issue 2, Pages (August 2003)

Volume 82, Issue 3, Pages (August 2012)

Volume 61, Issue 1, Pages (January 2002)

The Iranian model of living renal transplantation

Blood lead and chronic kidney disease in the general United States population: Results from NHANES III Paul Muntner, Jiang He, Suma Vupputuri, Josef.

Volume 80, Issue 10, Pages (November 2011)

Michael R. Lattanzio, Matthew R. Weir Kidney International

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Volume 59, Issue 2, Pages (February 2001)

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Volume 61, Issue 2, Pages (February 2002)

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Estimated survival probability curve in recipients of renal transplants in multivariable–adjusted Cox proportional hazard regression model 2. Estimated.

Presentation transcript:

Volume 64, Issue 3, Pages 1071-1079 (September 2003) Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States Austin G. Stack, Donald A. Molony, Noor S. Rahman, Akinsansoye Dosekun, Bhamidipati Murthy Kidney International Volume 64, Issue 3, Pages 1071-1079 (September 2003) DOI: 10.1046/j.1523-1755.2003.00165.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Adjusted Cox survival curves for new diabetic end-stage renal disease (ESRD) patients with and without congestive heart failure (CHF) treated with peritoneal dialysis (PD) versus hemodialysis (HD). Adjusted for age at study start, gender, race, cause of ESRD, hypertension, coronary artery disease (CAD), peripheral vascular and cerebrovascular disease, tobacco use, chronic lung disease, acquired immunodeficiency syndrome (AIDS), neoplasm, serum albumin, body mass index (BMI), hematocrit, estimated glomerular filtration rate (GFR), and pre-ESRD erythropoietin use. For CHF, PD/HD comparison, P < 0.0001; no CHF PD/HD comparison, P < 0.01. Kidney International 2003 64, 1071-1079DOI: (10.1046/j.1523-1755.2003.00165.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted Cox survival curves for new nondiabetic end-stage renal disease (ESRD) patients with and without congestive heart failure (CHF) treated with peritoneal dialysis (PD) versus hemodialysis (HD). Adjusted for age at study start, gender, race, cause of ESRD, hypertension, coronary artery disease (CAD), peripheral vascular and cerebrovascular disease, tobacco use, chronic lung disease, acquired immunodeficiency syndrome (AIDS), neoplasm, serum albumin, body mass index (BMI), hematocrit, estimated glomerular filtration rate (GFR), and pre-ESRD erythropoietin use. For CHF, PD/HD comparison, P < 0.0001; no CHF PD/HD comparison, P = NS. Kidney International 2003 64, 1071-1079DOI: (10.1046/j.1523-1755.2003.00165.x) Copyright © 2003 International Society of Nephrology Terms and Conditions